Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal tubes, tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. In addition, it offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. Further, it provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, erythrocyte sedimentation rate pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, and universal caps. The company was incorporated in 1995 and is based in New Delhi, India.
Poly Medicure Dividend Announcement
• Poly Medicure announced a annually dividend of ₹3.00 per ordinary share which will be made payable on 2024-10-26. Ex dividend date: 2024-09-19
• Poly Medicure annual dividend for 2024 was ₹3.00
• Poly Medicure annual dividend for 2023 was ₹3.00
• Poly Medicure's trailing twelve-month (TTM) dividend yield is 0.1%
• Poly Medicure's dividend growth over the last five years (2018-2023) was 8.45% year
• Poly Medicure's dividend growth over the last ten years (2013-2023) was 4.14% year
Poly Medicure Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-19 | ₹3.00 | annually | 2024-10-26 |
2023-09-21 | ₹3.00 | annually | 2023-10-28 |
2022-09-16 | ₹2.50 | annually | 2022-10-25 |
2021-09-16 | ₹2.50 | annually | 2021-10-24 |
2020-02-27 | ₹2.00 | annually | 2020-03-19 |
2019-09-13 | ₹2.00 | annually | 2019-10-23 |
2018-09-18 | ₹2.00 | annually | 2018-10-26 |
2017-09-20 | ₹0.50 | annually | 2017-10-28 |
2017-02-15 | ₹1.00 | annually | 2017-03-08 |
2016-11-11 | ₹1.00 | annually | 2016-12-08 |
2016-09-19 | ₹0.50 | annually | 2016-10-27 |
2016-03-17 | ₹2.50 | annually | 2016-03-30 |
2015-09-18 | ₹2.50 | annually | 2015-10-28 |
2014-09-15 | ₹4.00 | annually | 2014-10-23 |
2013-09-19 | ₹2.00 | annually | 2013-10-27 |
Poly Medicure Dividend per year
Poly Medicure Dividend growth
Poly Medicure Dividend Yield
Poly Medicure current trailing twelve-month (TTM) dividend yield is 0.1%. Interested in purchasing Poly Medicure stock? Use our calculator to estimate your expected dividend yield:
Poly Medicure Financial Ratios
Poly Medicure Dividend FAQ
Other factors to consider when evaluating Poly Medicure as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Poly Medicure stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Poly Medicure's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Poly Medicure publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Poly Medicure distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Poly Medicure are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Poly Medicure sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Poly Medicure distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Poly Medicure declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Poly Medicure's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Poly Medicure's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.